share_log

MangoRx Accepting Pre Orders For Its "PRIME", by MangoRx, Powered By Kyzatrex FDA Approved Oral Testosterone Replacement Therapy Product

MangoRx Accepting Pre Orders For Its "PRIME", by MangoRx, Powered By Kyzatrex FDA Approved Oral Testosterone Replacement Therapy Product

MangorX 接受 MangorX 的 “PRIME” 的預購,由 Kyzatrex FDA 批准的口服睾丸激素替代療法產品提供支持
Benzinga ·  02/05 08:52
The Dallas Based, Direct-to-Consumer Telemedicine Company to Offer 2 Months of Free 'PRIME' by MangoRx, Powered by Kyzatrex (a $498 value) for First 1,000 Subscribers
這家總部位於達拉斯的直接面向消費者的遠程醫療公司將提供由Kyzatrex提供支持的MangorX爲期2個月的免費 “PRIME”(價值498美元) 對於前 1,000 名訂閱者
Dallas, Texas, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling a variety of men's health and wellness products via a secure telemedicine platform, including its uniquely formulated hair growth product ('GROW') and erectile dysfunction (ED) drug ('Mango'), is excited to announce that it is offering 2 months of free 'PRIME' by MangoRx, Powered by Kyzatrex ("PRIME") (a $498 value) for the first 1,000 male subscribers who express...
得克薩斯州達拉斯,2024年2月5日(GLOBE NEWSWIRE)——Mangoceuticals, Inc.(納斯達克股票代碼:MGRX)(“Man...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論